Amazon’s $3.9 billion acquisition of primary care company One Medical was finalized last week without a regulatory challenge. Consumer protection groups say the deal shouldn’t have been allowed to close, citing a number of concerns — some of which are shared by the Federal Trade Commission. The agency, which reportedly had prepared a lawsuit to block the deal, could still sue to unwind the transaction farther down the road. Still, antitrust and M&A experts said that if regulators had found a reason to block the deal, they already would have.
Read the full article: Why Regulators Didn’t Challenge Amazon-One Medical Deal, despite Data Concerns //
Source: https://www.healthcaredive.com/news/why-regulators-didnt-challenge-amazon-one-medical-deal-data/643316